Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2025-12-29 @ 3:59 AM
Study NCT ID:
NCT07185269
Status:
RECRUITING
Last Update Posted:
2025-11-26
First Post:
2025-09-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Purpose of This Study is to Evaluate the Efficacy and Safety of 626 in the Treatment of SLE
Sponsor:
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SSGJ-626-SLE-Ib/II-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None